Entropy Neurodynamics Limited (ENP) - Net Assets
Based on the latest financial reports, Entropy Neurodynamics Limited (ENP) has net assets worth AU$5.96 Million AUD (≈ $4.22 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$6.66 Million ≈ $4.71 Million USD) and total liabilities (AU$699.17K ≈ $494.71K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Entropy Neurodynamics Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$5.96 Million |
| % of Total Assets | 89.51% |
| Annual Growth Rate | N/A |
| 5-Year Change | -68.39% |
| 10-Year Change | N/A |
| Growth Volatility | 112.45 |
Entropy Neurodynamics Limited - Net Assets Trend (2018–2025)
This chart illustrates how Entropy Neurodynamics Limited's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Entropy Neurodynamics Limited for the complete picture of this company's asset base.
Annual Net Assets for Entropy Neurodynamics Limited (2018–2025)
The table below shows the annual net assets of Entropy Neurodynamics Limited from 2018 to 2025. For live valuation and market cap data, see Entropy Neurodynamics Limited market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$5.96 Million ≈ $4.22 Million |
+6.12% |
| 2024-06-30 | AU$5.62 Million ≈ $3.98 Million |
+36.18% |
| 2023-06-30 | AU$4.13 Million ≈ $2.92 Million |
-53.14% |
| 2022-06-30 | AU$8.81 Million ≈ $6.23 Million |
-53.32% |
| 2021-06-30 | AU$18.87 Million ≈ $13.35 Million |
+276.03% |
| 2020-06-30 | AU$5.02 Million ≈ $3.55 Million |
-2.00% |
| 2019-06-30 | AU$5.12 Million ≈ $3.62 Million |
+70540.08% |
| 2018-06-30 | AU$-7.27K ≈ $-5.14K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Entropy Neurodynamics Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3522893000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$35.31 Million | 592.12% |
| Other Comprehensive Income | AU$6.06 Million | 101.54% |
| Total Equity | AU$5.96 Million | 100.00% |
Entropy Neurodynamics Limited Competitors by Market Cap
The table below lists competitors of Entropy Neurodynamics Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
M K Land Holdings Bhd
KLSE:8893
|
$42.34 Million |
|
Unique Optical Industrial Co Ltd
TWO:3441
|
$42.39 Million |
|
Chih Lien Industrial Co Ltd
TW:2024
|
$42.39 Million |
|
Sentien Printing Factory Co Ltd
TWO:8410
|
$42.42 Million |
|
3U Holding AG
XETRA:UUU
|
$42.34 Million |
|
PTRB
KLSE:0260
|
$42.31 Million |
|
Wonik Cube Corp
KQ:014190
|
$42.31 Million |
|
Gigas Hosting S.A
MC:GIGA
|
$42.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Entropy Neurodynamics Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,620,140 to 5,963,916, a change of 343,776 (6.1%).
- Net loss of 5,332,421 reduced equity.
- Share repurchases of 403,555 reduced equity.
- New share issuances of 6,000,000 increased equity.
- Other comprehensive income increased equity by 275,779.
- Other factors decreased equity by 196,027.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-5.33 Million | -89.41% |
| Share Repurchases | AU$403.56K | -6.77% |
| Share Issuances | AU$6.00 Million | +100.61% |
| Other Comprehensive Income | AU$275.78K | +4.62% |
| Other Changes | AU$-196.03K | -3.29% |
| Total Change | AU$- | 6.12% |
Book Value vs Market Value Analysis
This analysis compares Entropy Neurodynamics Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-06-30 | AU$0.00 | AU$0.04 | x |
| 2019-06-30 | AU$0.20 | AU$0.04 | x |
| 2020-06-30 | AU$0.12 | AU$0.04 | x |
| 2021-06-30 | AU$0.32 | AU$0.04 | x |
| 2022-06-30 | AU$0.12 | AU$0.04 | x |
| 2023-06-30 | AU$0.05 | AU$0.04 | x |
| 2024-06-30 | AU$0.01 | AU$0.04 | x |
| 2025-06-30 | AU$0.00 | AU$0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Entropy Neurodynamics Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -89.41%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -335.91%
- • Asset Turnover: 0.24x
- • Equity Multiplier: 1.12x
- Recent ROE (-89.41%) is below the historical average (-85.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | AU$-173.87K |
| 2019 | -44.59% | 0.00% | 0.00x | 1.05x | AU$-2.79 Million |
| 2020 | -105.21% | 0.00% | 0.00x | 1.30x | AU$-5.78 Million |
| 2021 | -44.88% | 0.00% | 0.00x | 1.14x | AU$-10.35 Million |
| 2022 | -114.49% | -10111.31% | 0.01x | 1.55x | AU$-10.96 Million |
| 2023 | -172.77% | -1152.70% | 0.11x | 1.43x | AU$-7.54 Million |
| 2024 | -109.30% | -548.74% | 0.15x | 1.33x | AU$-6.70 Million |
| 2025 | -89.41% | -335.91% | 0.24x | 1.12x | AU$-5.93 Million |
Industry Comparison
This section compares Entropy Neurodynamics Limited's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $8,264,074
- Average return on equity (ROE) among peers: -154.79%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Entropy Neurodynamics Limited (ENP) | AU$5.96 Million | 0.00% | 0.12x | $42.34 Million |
| Adalta Ltd (1AD) | $172.82K | -722.64% | 1.66x | $6.50 Million |
| Algorae Pharmaceuticals Ltd (1AI) | $-1.33 Million | 0.00% | 0.00x | $20.04 Million |
| ACRUX Ltd (ACR) | $11.66 Million | -0.09% | 0.10x | $3.20 Million |
| Actinogen Medical Ltd (ACW) | $13.41 Million | -80.20% | 0.13x | $103.45 Million |
| Argenica Therapeutics Ltd (AGN) | $7.24 Million | -99.08% | 0.53x | $15.45 Million |
| Arovella Therapeutics Ltd (ALA) | $11.23 Million | -77.89% | 0.18x | $59.79 Million |
| Anatara Lifesciences Ltd (ANR) | $-16.00K | 0.00% | 0.00x | $1.57 Million |
| Alterity Therapeutics Ltd (ATH) | $13.80 Million | -138.60% | 0.39x | $76.95 Million |
| Amplia Therapeutics Ltd (ATX) | $21.02 Million | -31.26% | 0.09x | $54.45 Million |
| Avecho Biotechnology Ltd (AVE) | $5.45 Million | -398.12% | 0.01x | $31.19 Million |
About Entropy Neurodynamics Limited
Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States. The company's lead program candidate is TRP-8803, a formulation of IV-infused psilocin that completed Phase 2 … Read more